CanSinoBIO's inhaled COVID booster more effective against BA.1 Omicron subvariant than Sinovac's injectable
August 02, 2022 at 08:39 AM EDT
China's CanSinoBio's inhalable coronavirus booster has shown to provide better protection against the BA.1 Omicron subvariant than Sinovac's injectable boosters in clinical trials.
